Sepax PolyRP Columns
Description
PolyRP phases are made of 80% cross-linking PS/DVB spherical particles. These highly rigid particles
have both non-porous and porous structures with the particle size selection of 1.7, 3, 5, and 10 µm.
The phase structure is phenyl functional groups that enable hydrophobic interaction. Compared with
silica based reversed phases, PolyRP phases have advantages over applications at extreme pH (1-14)
with special selectivity and slightly lower separation efficiency.
Packing
Porous Resins
|
PS/DVB Particles:
|
Spherical, 80% cross-linking
|
|
Pore size:
|
100, 300, 500, and 1000 Å
|
|
Particle size:
|
5 and 10 µm
|
|
Pore volume:
|
1.0 ml/g
|
|
Surface area:
|
280 m²/g for 100 Å pore size
|
|
Phase structure:
|
phenyl group
|
|
Separation mechanism:
|
hydrophobic interaction
|
Non-Porous Resins
|
PS/DVB Particles:
|
Spherical, 80% cross-linking
|
|
Pore size:
|
non-porous
|
|
Particle size:
|
1.7, 3, 5, and 10 µm
|
|
Surface area:
|
<10 m²/g
|
|
Phase structure:
|
phenyl group
|
|
Separation mechanism:
|
hydrophobic interaction
|
Characteristic
· Uniform particles and narrow pore size distribution
· Extremely high chemical stability
· Unsurpassed pH stability (1-14)
· High retentativity
· Unique selectivity
· High mechanical stability
· Suitable for separations of pharmaceuticals, acidic, neutral and basic organic compounds,
and organic acids
· Separation of peptides, amino acids, and proteins
bio-equip.cn
Profile
Sepax Technologies, Inc., a privately held company, was founded in Delaware, USA in November 2002. It develops and manufactures HPLC consumables, bulk media, and equipment in liquid chromatography for chemical and biological separations. It is a fast growing technology company and owns patents, proprietary technologies and know-how. Sepax has emerged as a leader in the biological separation industry in the global market.
Business strategies
Sepax Technologies, Inc. develops innovative HPLC consumables, bulk media, and instruments to solve separation challenges in the global market. We provide solution-based products by closely working with our customer scientists in pharmaceuticals, biopharmaceuticals, research institutes and government labs. Our strong technical team develops various methods with our customers to analyze complex biological molecules. As a leader in the biological separation industry, we constantly develop the best bio-separation technologies and products for our global customers. We have reached a competitive position globally in fast growing regions.
Vision Statement
To become a technology leader in the biological separation industry in the global market and provide solution based products and services for our customers.
Operation
Sepax Technologies, Inc.
Our company headquarter in Delaware is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development of separation resin technologies and instrumentation, production of HPLC resins, columns and CE consumables. It is also the marketing and sales center for our US and global markets.
Sales
Domestic
Audrey Fisher
Field Sales Account Manager
(Northern CA areas, UT, CO, OR)
Direct Phone: 925-324-5223
Email: afisher@sepax-tech.com
Kathleen Falls
West Coast Regional Manager
(All other CA areas, WA, TX, AZ, NM, MI)
Direct Phone: 323-228-0004
Email: kfalls@sepax-tech.com
Michael Hunnewell
Field Sales Account Manager
(MA, RI, NH, CT, NY)
Direct Phone: 302-650-3955
Email: mhunnewell@sepax-tech.com
Colleen Callahan
Midwest Account Manager
(WI, IL, IN, OH, MO)
Direct Phone: 302-366-1101, ext 106
Cell Phone: 302-339-8747
Email: ccallahan@sepax-tech.com
All other areas, please contact
Helen Gu
Vice President, Sales
Direct phone: 302-650-3909
Email: hgu@sepax-tech.com
International
Tingting Wu
Executive Account Manager/Marketing
Phone: 302-366-1101, ext 115
Email: twu@sepax-tech.com
中文
